Literature DB >> 25152346

Oral medications.

Dee Anna Glaser1.   

Abstract

Primary hyperhidrosis commonly affects the axillae, palms, soles, scalp, face, and groin. Patients may have multiple areas involved making localized therapy challenging. Systemic therapy may be necessary and can be used as monotherapy or combined with other hyperhidrosis treatments for optimal outcomes. Systemic therapy can also be used to treat secondary hyperhidrosis and compensatory hyperhidrosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticholinergic; Clonidine; Glycopyrrolate; Hyperhidrosis; Oxybutynin; Propanolol; Systemic therapy; β-blocker

Mesh:

Substances:

Year:  2014        PMID: 25152346     DOI: 10.1016/j.det.2014.06.002

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

Review 1.  Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities.

Authors:  Anna Kisielnicka; Aneta Szczerkowska-Dobosz; Dorota Purzycka-Bohdan; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2022-05-09       Impact factor: 1.664

Review 2.  Oxybutynin as an alternative treatment for hyperhidrosis.

Authors:  Sergio Delort; Evaldo Marchi; Marcos Antônio Corrêa
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

Review 3.  Current and Emerging Medical Therapies for Primary Hyperhidrosis.

Authors:  Daniel A Grabell; Adelaide A Hebert
Journal:  Dermatol Ther (Heidelb)       Date:  2016-10-27

4.  Chinese expert consensus on the surgical treatment of primary palmar hyperhidrosis (2021 version).

Authors:  Yanguo Liu; Wenhan Weng; Yuanrong Tu; Jun Wang
Journal:  Chin Med J (Engl)       Date:  2022-06-05       Impact factor: 6.133

5.  Atypical aquagenic keratoderma treated with oxybutynin chloride.

Authors:  Niharika Dixit; Kabir Sardana; Sidharth Tandon; Yogita Singh
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.